We are live on ! Find out more
BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
+17.11%
1 Year Est. Return
+95.04%
3 Year Est. Return
+233.14%
5 Year Est. Return
+280.2%
10 Year Est. Return
+1,023.63%
AUM
$174M
AUM Growth
+$23.9M
Cap. Flow
+$13.2M
Cap. Flow %
7.62%
Top 10 Hldgs %
75.05%
Holding
53
New
3
Increased
5
Reduced
3
Closed
5

Top Buys

Rank Stock Value
1
BDSX icon
Biodesix
BDSX
+$17.2M
2
FHTX icon
Foghorn Therapeutics
FHTX
+$6.02M
3
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
+$1.47M
4
ALBO
Albireo Pharma Inc
ALBO
+$1.24M
5
KPTI icon
Karyopharm Therapeutics
KPTI
+$309K

Top Sells

Rank Stock Value
1
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$10M
2
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$1.36M
3
EPZM
Epizyme, Inc
EPZM
+$835K
4
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$344K
5
VYGR icon
Voyager Therapeutics
VYGR
+$320K

Sector Composition

Rank Sector Weight
1 Healthcare 96.79%
2 Energy 1.15%
3 Consumer Staples 0.06%
4 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICPT
51
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-8,300
Closed -$344K
EPZM
52
DELISTED
Epizyme, Inc
EPZM
– –
-70,000
Closed -$835K
MYOK
53
DELISTED
MyoKardia, Inc. Common Stock
MYOK
– –
-10,000
Closed -$1.36M
1 2
3

Similar funds

RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BAM
Boyar Asset Management New York $176M AUM 20.04% 1-Year Est. Return
TIM
Tevis Investment Management Plano, Texas $176M AUM 18.14% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $176M AUM
PFA
Providence Financial Advisors Overland Park, Kansas $175M AUM
DAM
Draper Asset Management Smithtown, New York $176M AUM 37.45% 1-Year Est. Return
AF
Align Financial Hermantown, Minnesota $176M AUM
OA
Oceanside Advisors Mount Pleasant, South Carolina $175M AUM 17.96% 1-Year Est. Return

Birchview Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Birchview Capital held 53 positions worth $174M, up 16% from $150M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Birchview Capital deployed $13.2M of net new capital in Q4 2020, opening 3 new positions and adding to 5 existing holdings. Its largest new stake was Biodesix: 55,254 shares worth $22.3M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 95% a quarter earlier, followed by Energy and Consumer Staples.

On the sell side, the largest reduction was Aspira Women's Health Inc. Common Stock, an estimated $10M trimmed.

  • Birchview Capital's largest Q4 2020 buy was Biodesix: 55,254 shares worth $22.3M.
  • Birchview Capital added most to Albireo Pharma Inc in Q4 2020, an estimated $1.24M increase.
  • Birchview Capital's biggest Q4 2020 reduction was Aspira Women's Health Inc. Common Stock, cutting an estimated $10M.
  • Birchview Capital fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $1.36M.
  • Birchview Capital's ten largest holdings make up 75% of its $174M portfolio in Q4 2020.
  • Birchview Capital opened 3 new positions and closed 5 in Q4 2020.
  • Birchview Capital's portfolio value rose 16% quarter-over-quarter to $174M.

Based on Birchview Capital's 13F filing for Q4 2020, filed 9 Feb 2021.